[ad_1]
Jakarta, CNBC Indonesia – The Chinese-made Covid-19 corona virus vaccine is likely to be ready for public use in November 2020. This is a statement from the China Center for Disease Control and Prevention (CDC), cited by Reuters on Tuesday (9/15/2020).
China has four Covid-19 vaccines that have entered end-phase clinical trials. Three of them are known to have been offered to coronavirus front-line workers in an emergency use program in July 2020.
Biosafety chief Guizhen Wu said phase three of the clinical trials is progressing smoothly and the vaccine will be ready for use in November or December.
He also said that he had not experienced any abnormal side effects in recent months after receiving the experimental vaccine in April. Unfortunately, he did not explain what vaccine he was injected with.
Units of the state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and Sinovac Biotech are developing three vaccines under the state’s emergency use program. The fourth Covid-19 vaccine being developed by CanSino Biologics was approved for use by the Chinese military in June.
Sinopharm said in July that its vaccine could be ready for public use later this year following the completion of Phase 3 trials.
[Gambas:Video CNBC](roy / miq)
